Kurt M Poindexter

Title: Kurt M. Poindexter: Innovator in Angiogenesis Inhibition

Introduction

Kurt M. Poindexter is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biomedical research, particularly in the area of angiogenesis inhibition. His work focuses on the development of methods and compositions that target integrins to inhibit endothelial cell migration and angiogenesis.

Latest Patents

Kurt M. Poindexter holds a patent for the "Use of integrin antagonists to inhibit angiogenesis." This invention provides methods and compositions for inhibiting the biological activity of integrins, which are crucial in the process of angiogenesis. The patent outlines compositions that include ADAM disintegrin domains and methods for utilizing these compositions to treat diseases or conditions mediated by angiogenesis. He has 1 patent to his name.

Career Highlights

Kurt is associated with Immunex Corporation, where he has contributed to innovative research and development in the field of biotechnology. His work has implications for various medical conditions that involve abnormal blood vessel growth.

Collaborations

Throughout his career, Kurt has collaborated with esteemed colleagues such as William C. Fanslow, III, and Douglas Pat Cerretti. These collaborations have furthered research efforts in the field and have led to advancements in therapeutic strategies.

Conclusion

Kurt M. Poindexter's contributions to the field of angiogenesis inhibition highlight his role as an innovator in biomedical research. His patent and work at Immunex Corporation demonstrate his commitment to advancing medical science and improving treatment options for patients.